Heron Therapeutics, Inc. (HRTX)

NASDAQ: HRTX · IEX Real-Time Price · USD

3.250

-0.080 (-2.40%)

At close: Jul 19, 2024, 4:00 PM

3.170

-0.080 (-2.46%)

Pre-market: Jul 20, 2024, 9:29 AM EDT

Heron Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 1994
Revenue	132.1	127.04	107.67	86.35	88.64	145.97	Upgrade
Revenue Growth (YoY)	16.05%	17.99%	24.70%	-2.59%	-39.28%	88.41%	Upgrade
Cost of Revenue	56.7	65.11	54.87	46.02	36.19	61.62	Upgrade
Gross Profit	75.4	61.94	52.8	40.33	52.45	84.35	Upgrade
Selling, General & Admin	111.07	116.66	119.95	127.33	106.08	127.66	Upgrade
Research & Development	46.69	55.9	107.51	130.82	174.53	167.38	Upgrade
Other Operating Expenses	0	0	0	0.88	0	0	Upgrade
Operating Expenses	157.75	172.55	227.46	259.03	280.61	295.04	Upgrade
Operating Income	-82.35	-110.62	-174.66	-218.71	-228.16	-210.69	Upgrade
Interest Expense / Income	0.5	0.5	0.84	1.98	-1.73	-5.79	Upgrade
Other Expense / Income	-1.9	-0.56	6.53	-	0.85	-0.16	Upgrade
Pretax Income	-80.95	-110.56	-182.02	-220.68	-227.28	-204.75	Upgrade
Net Income	-80.95	-110.56	-182.02	-220.68	-227.28	-204.75	Upgrade
Shares Outstanding (Basic)	151	138	109	98	91	82	Upgrade
Shares Outstanding (Diluted)	151	138	109	98	91	82	Upgrade
Shares Change	26.80%	26.87%	10.57%	8.48%	11.00%	11.73%	Upgrade
EPS (Basic)	-0.59	-0.80	-1.67	-2.24	-2.50	-2.50	Upgrade
EPS (Diluted)	-0.59	-0.80	-1.67	-2.24	-2.50	-2.50	Upgrade
Free Cash Flow	-44.71	-60.32	-148.51	-206.34	-191.63	-131.73	Upgrade
Free Cash Flow Per Share	-0.30	-0.44	-1.36	-2.10	-2.11	-1.61	Upgrade
Gross Margin	57.08%	48.75%	49.04%	46.70%	59.17%	57.79%	Upgrade
Operating Margin	-62.34%	-87.07%	-162.21%	-253.29%	-257.41%	-144.34%	Upgrade
Profit Margin	-61.28%	-87.02%	-169.05%	-255.58%	-256.41%	-140.27%	Upgrade
Free Cash Flow Margin	-33.85%	-47.48%	-137.93%	-238.97%	-216.20%	-90.25%	Upgrade
EBITDA	-77.58	-107.16	-178.3	-215.69	-226.16	-208.49	Upgrade
EBITDA Margin	-58.73%	-84.35%	-165.59%	-249.79%	-255.15%	-142.83%	Upgrade
Depreciation & Amortization	2.87	2.9	2.89	3.02	2.85	2.04	Upgrade
EBIT	-80.45	-110.06	-181.19	-218.71	-229.01	-210.54	Upgrade
EBIT Margin	-60.90%	-86.63%	-168.28%	-253.29%	-258.37%	-144.23%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).